Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical

RSS  

Articles

  • Pharmacology Watch: FDA Drug Approval to Change its Ways?

    In This Issue: FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
  • Special Feature: Amniocentesis Today — Is It Really A Benign Procedure?

    Over the last five years, there has been an increased emphasis on screening for aneuploidy, in part due to the ACOG endorsement of the concept of offering nuchal translucency (NT) and biochemical screening to all pregnant patients, and not just those of advanced maternal age (AMA).
  • Does Anyone Still Do Routine Episiotomies?

    It is unclear how many practitioners around the world use routine episiotomy today as a way to avoid third and fourth degree lacerations. There certainly was a period of time when episiotomy was a routine practice in nulliparas.
  • Is The Maintenance of Oxic Cancer ... Toxic?

    The primary purpose of this phase III study was to determine if maintenance of hemoglobin values above 12 g/dL by use of R-HUEPO during chemoradiotherapy (weekly cisplatin) for advanced cervix cancer was associated with improved outcomes (progression-free and overall survival and local control rates) relative to maintenance of hemoglobin values above 10 g/dL by way of non-R-HUEPO methods.
  • Blood clots and "The Patch"

    By Alison Edelman, MD, MPH, Assistant Professor, Assistant Director of the Family Planning Fellowship Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, is Associate Editor for OB/GYN Clinical Alert.
  • ECG Review: A "Run of VT"

    Simultaneously recorded leads II and MCL1 rhythm strip obtained from a middle-aged adult with heart disease. Despite this "run of VT", the patient remained alert, hemodynamically stable, and asymptomatic during tachycardia.
  • Lanreotide Injection (Somatulin® Depot)

    A second somatostatin (growth hormone inhibiting hormone) analog is available for the long-term treatment of acromegaly in patients who have not responded to other treatment modalities.
  • Breast Size Not All It's Stacked up to Be

    Bra cup size at age 20 predicts risk of diabetes mellitus in later life.
  • Pharmacology Watch

    Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
  • Clinical Briefs by Louis Kuritzky, MD

    Erectile dysfunction (ED) most commonly reflects endothelial dysfunction of the corpora cavernosa. Because the risk factors for ED have been determined to be the same as those for cardiovascular disease (CVD), the concept that ED might actually be a predictor for CVD has garnered some support.